ANDA 207792, held by Amneal Pharms Ny. Isotretinoin.
As of Nov 16, 2026, ANDA 207792 (Isotretinoin), held by Amneal Pharms Ny, was first approved by FDA on Sep 29, 2017, with 13 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 29, 2017 | Original application | Approved |
| Isotretinoin10MG · capsule;oral | Isotretinoin | Rx |
| Isotretinoin20MG · capsule;oral | Isotretinoin | Rx |
| Isotretinoin30MG · capsule;oral | Isotretinoin | Rx |
| Isotretinoin40MG · capsule;oral | Isotretinoin | Rx |
| Oct 7, 2026 | Supplement 38REMS | Approved | None posted |
| Aug 21, 2026 | Supplement 36Labeling · Standard review | Approved | None posted |
| Feb 9, 2026 | Supplement 30REMS | Approved | None posted |
| Jun 26, 2024 | Supplement 22Labeling · Standard review | Approved | None posted |
| Mar 24, 2023 | Supplement 24REMS | Approved | None posted |
| Oct 6, 2022 | Supplement 20REMS | Approved | None posted |
| Aug 24, 2022 | Supplement 19Labeling · Standard review | Approved | None posted |
| Nov 8, 2021 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 8, 2021 | Supplement 14REMS | Approved | None posted |
| Dec 9, 2020 | Supplement 11REMS | Approved | None posted |
| Aug 31, 2018 | Supplement 5Labeling · Standard review | Approved | None posted |
| May 2, 2018 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 23, 2018 | Supplement 3REMS | Approved | None posted |
| Sep 29, 2017 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters